Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 172

1.

Motor and non-motor outcomes in patients with advanced Parkinson's disease treated with levodopa/carbidopa intestinal gel: final results of the GREENFIELD observational study.

Lopiano L, Modugno N, Marano P, Sensi M, Meco G, Solla P, Gusmaroli G, Tamma F, Mancini F, Quatrale R, Zangaglia R, Bentivoglio A, Eleopra R, Gualberti G, Melzi G, Antonini A.

J Neurol. 2019 Sep;266(9):2164-2176. doi: 10.1007/s00415-019-09337-6. Epub 2019 May 27.

2.

DAT gene polymorphisms (rs28363170, rs393795) and levodopa-induced dyskinesias in Parkinson's disease.

Purcaro C, Vanacore N, Moret F, Di Battista ME, Rubino A, Pierandrei S, Lucarelli M, Meco G, Fattapposta F, Pascale E.

Neurosci Lett. 2019 Jan 18;690:83-88. doi: 10.1016/j.neulet.2018.10.021. Epub 2018 Oct 11.

PMID:
30316985
3.

LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study.

Quadri M, Mandemakers W, Grochowska MM, Masius R, Geut H, Fabrizio E, Breedveld GJ, Kuipers D, Minneboo M, Vergouw LJM, Carreras Mascaro A, Yonova-Doing E, Simons E, Zhao T, Di Fonzo AB, Chang HC, Parchi P, Melis M, Correia Guedes L, Criscuolo C, Thomas A, Brouwer RWW, Heijsman D, Ingrassia AMT, Calandra Buonaura G, Rood JP, Capellari S, Rozemuller AJ, Sarchioto M, Fen Chien H, Vanacore N, Olgiati S, Wu-Chou YH, Yeh TH, Boon AJW, Hoogers SE, Ghazvini M, IJpma AS, van IJcken WFJ, Onofrj M, Barone P, Nicholl DJ, Puschmann A, De Mari M, Kievit AJ, Barbosa E, De Michele G, Majoor-Krakauer D, van Swieten JC, de Jong FJ, Ferreira JJ, Cossu G, Lu CS, Meco G, Cortelli P, van de Berg WDJ, Bonifati V; International Parkinsonism Genetics Network.

Lancet Neurol. 2018 Jul;17(7):597-608. doi: 10.1016/S1474-4422(18)30179-0. Epub 2018 Jun 7.

PMID:
29887161
4.

Intercepting Parkinson disease non-motor subtypes: A proof-of-principle study in a clinical setting.

Di Battista ME, Cova I, Rubino A, Papi CP, Alampi G, Purcaro C, Vanacore N, Pascale E, Locuratolo N, Fattapposta F, Mariani C, Pomati S, Meco G.

J Neurol Sci. 2018 May 15;388:186-191. doi: 10.1016/j.jns.2018.03.024. Epub 2018 Mar 17.

PMID:
29627019
5.

Combining olfactory test and motion analysis sensors in Parkinson's disease preclinical diagnosis: a pilot study.

Maremmani C, Cavallo F, Purcaro C, Rossi G, Salvadori S, Rovini E, Esposito D, Pieroni A, Ramat S, Vanni P, Fattori B, Meco G.

Acta Neurol Scand. 2018 Feb;137(2):204-211. doi: 10.1111/ane.12862. Epub 2017 Oct 29.

PMID:
29082509
6.

Adaptation and psychometric properties of the Italian version of the Non-Motor Symptoms Questionnaire for Parkinson's disease.

Cova I, Di Battista ME, Vanacore N, Papi CP, Alampi G, Rubino A, Valente M, Meco G, Contri P, Di Pucchio A, Lacorte E, Priori A, Mariani C, Pomati S.

Neurol Sci. 2017 Apr;38(4):673-678. doi: 10.1007/s10072-017-2830-z. Epub 2017 Feb 1.

PMID:
28150102
7.

Mutations in TMEM230 are not a common cause of Parkinson's disease.

Quadri M, Breedveld GJ, Chang HC, Yeh TH, Guedes LC, Toni V, Fabrizio E, De Mari M, Thomas A, Tassorelli C, Rood JP, Saddi V, Chien HF, Kievit AJ, Boon AJ, Stocchi F, Lopiano L, Abbruzzese G, Cortelli P, Meco G, Cossu G, Barbosa ER, Ferreira JJ; International Parkinsonism Genetics Network, Lu CS, Bonifati V.

Mov Disord. 2017 Feb;32(2):302-304. doi: 10.1002/mds.26900. Epub 2017 Jan 16. No abstract available.

PMID:
28090676
8.

Validation of the Italian version of the Non Motor Symptoms Scale for Parkinson's disease.

Cova I, Di Battista ME, Vanacore N, Papi CP, Alampi G, Rubino A, Valente M, Meco G, Contri P, Di Pucchio A, Lacorte E, Priori A, Mariani C, Pomati S.

Parkinsonism Relat Disord. 2017 Jan;34:38-42. doi: 10.1016/j.parkreldis.2016.10.020. Epub 2016 Oct 24.

9.

Cardiovascular dysfunction in untreated Parkinson's disease: A multi-modality assessment.

Strano S, Fanciulli A, Rizzo M, Marinelli P, Palange P, Tiple D, De Vincentis G, Calcagnini G, Censi F, Meco G, Colosimo C.

J Neurol Sci. 2016 Nov 15;370:251-255. doi: 10.1016/j.jns.2016.09.036. Epub 2016 Sep 21.

PMID:
27772769
10.

Motor outcomes in patients with advanced Parkinson's disease treated with levodopa/carbidopa intestinal gel in Italy: an interim analysis from the GREENFIELD observational study.

Lopiano L, Modugno N, Marano P, Sensi M, Meco G, Cannas A, Gusmaroli G, Tamma F, Mancini F, Quatrale R, Costanzo AM, Gualberti G, Melzi G, di Luzio Paparatti U, Antonini A.

Neurol Sci. 2016 Nov;37(11):1785-1792. Epub 2016 Jul 15.

11.

Genetic Architecture of MAPT Gene Region in Parkinson Disease Subtypes.

Pascale E, Di Battista ME, Rubino A, Purcaro C, Valente M, Fattapposta F, Ferraguti G, Meco G.

Front Cell Neurosci. 2016 Apr 11;10:96. doi: 10.3389/fncel.2016.00096. eCollection 2016.

12.

Erratum to: Is cognitive stability in Parkinson's disease a predictable phenomenon? A 5-year follow-up study.

Di Battista ME, Rubino A, Valente M, Giustini P, Vanacore N, Meco G.

J Neural Transm (Vienna). 2015 Dec;122(12):1707. doi: 10.1007/s00702-015-1474-5. No abstract available.

PMID:
26546036
13.

Is cognitive stability in Parkinson's disease a predictable phenomenon? A 5-year follow-up study.

Di Battista ME, Rubino A, Valente M, Giustini P, Vanacore N, Meco G.

J Neural Transm (Vienna). 2015 Dec;122(12):1703-6. doi: 10.1007/s00702-015-1440-2. Epub 2015 Aug 28. Erratum in: J Neural Transm (Vienna). 2015 Dec;122(12):1707.

PMID:
26315579
14.

A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non-demented Parkinson's disease patients.

Barone P, Santangelo G, Morgante L, Onofrj M, Meco G, Abbruzzese G, Bonuccelli U, Cossu G, Pezzoli G, Stanzione P, Lopiano L, Antonini A, Tinazzi M.

Eur J Neurol. 2015 Aug;22(8):1184-91. doi: 10.1111/ene.12724. Epub 2015 May 12.

15.

Reversible Pisa syndrome associated to subdural haematoma: case-report.

Marchione P, Spallone A, Valente M, Giannone C, De Angelis F, Meco G.

BMC Neurol. 2014 Aug 14;14:149. doi: 10.1186/1471-2377-14-149.

16.

Does a volume reduction of the parietal lobe contribute to freezing of gait in Parkinson's disease?

Rubino A, Assogna F, Piras F, Di Battista ME, Imperiale F, Chiapponi C, Spalletta G, Meco G.

Parkinsonism Relat Disord. 2014 Oct;20(10):1101-3. doi: 10.1016/j.parkreldis.2014.07.002. Epub 2014 Jul 29.

PMID:
25112926
17.

Clinical subtypes in Parkinson's disease: the impact of MAPT haplotypes.

Di Battista ME, Pascale E, Purcaro C, Passarelli F, Passarelli E, Guglielmi R, Vanacore N, Meco G.

J Neural Transm (Vienna). 2014 Apr;121(4):353-6. doi: 10.1007/s00702-013-1117-7. Epub 2013 Nov 20.

PMID:
24253235
18.

Depressive symptoms in Parkinson's disease and in non-neurological medical illnesses.

Assogna F, Fagioli S, Cravello L, Meco G, Pierantozzi M, Stefani A, Imperiale F, Caltagirone C, Pontieri FE, Spalletta G.

Neuropsychiatr Dis Treat. 2013;9:389-96. doi: 10.2147/NDT.S40013. Epub 2013 Mar 21.

19.

A cross-sectional multicenter study of cognitive and behavioural features in multiple system atrophy patients of the parkinsonian and cerebellar type.

Siri C, Duerr S, Canesi M, Delazer M, Esselink R, Bloem BR, Gurevich T, Balas M, Giladi N, Santacruz P, Marti F, Tolosa E, Rubino A, Meco G, Poewe W, Pezzoli G, Wenning G, Antonini A.

J Neural Transm (Vienna). 2013 Apr;120(4):613-8. doi: 10.1007/s00702-013-0997-x. Epub 2013 Mar 6.

PMID:
23462799
20.

L-Acetylcarnitine in dysthymic disorder in elderly patients: a double-blind, multicenter, controlled randomized study vs. fluoxetine.

Bersani G, Meco G, Denaro A, Liberati D, Colletti C, Nicolai R, Bersani FS, Koverech A.

Eur Neuropsychopharmacol. 2013 Oct;23(10):1219-25. doi: 10.1016/j.euroneuro.2012.11.013. Epub 2013 Feb 18.

PMID:
23428336
21.

The natural history of multiple system atrophy: a prospective European cohort study.

Wenning GK, Geser F, Krismer F, Seppi K, Duerr S, Boesch S, Köllensperger M, Goebel G, Pfeiffer KP, Barone P, Pellecchia MT, Quinn NP, Koukouni V, Fowler CJ, Schrag A, Mathias CJ, Giladi N, Gurevich T, Dupont E, Ostergaard K, Nilsson CF, Widner H, Oertel W, Eggert KM, Albanese A, del Sorbo F, Tolosa E, Cardozo A, Deuschl G, Hellriegel H, Klockgether T, Dodel R, Sampaio C, Coelho M, Djaldetti R, Melamed E, Gasser T, Kamm C, Meco G, Colosimo C, Rascol O, Meissner WG, Tison F, Poewe W; European Multiple System Atrophy Study Group.

Lancet Neurol. 2013 Mar;12(3):264-74. doi: 10.1016/S1474-4422(12)70327-7. Epub 2013 Feb 5.

22.

Hedonic tone and its mood and cognitive correlates in Parkinson's disease.

Spalletta G, Fagioli S, Meco G, Pierantozzi M, Stefani A, Pisani V, Caltagirone C, Pontieri FE, Assogna F.

Depress Anxiety. 2013 Jan;30(1):85-91. doi: 10.1002/da.22036.

PMID:
23300113
23.

A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's disease.

Bonuccelli U, Meco G, Fabbrini G, Tessitore A, Pierantozzi M, Stocchi F, Ceravolo R, Caltagirone C, Silvestrini M, Morgante F, Ruggieri S, Avanzino L, Guadagna M, Dell'Agnello G, Rossi A, Spezia R, Mancini M.

Expert Opin Pharmacother. 2012 Nov;13(16):2269-80. doi: 10.1517/14656566.2012.736490.

PMID:
23067321
24.

The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life.

Antonini A, Barone P, Marconi R, Morgante L, Zappulla S, Pontieri FE, Ramat S, Ceravolo MG, Meco G, Cicarelli G, Pederzoli M, Manfredi M, Ceravolo R, Mucchiut M, Volpe G, Abbruzzese G, Bottacchi E, Bartolomei L, Ciacci G, Cannas A, Randisi MG, Petrone A, Baratti M, Toni V, Cossu G, Del Dotto P, Bentivoglio AR, Abrignani M, Scala R, Pennisi F, Quatrale R, Gaglio RM, Nicoletti A, Perini M, Avarello T, Pisani A, Scaglioni A, Martinelli PE, Iemolo F, Ferigo L, Simone P, Soliveri P, Troianiello B, Consoli D, Mauro A, Lopiano L, Nastasi G, Colosimo C.

J Neurol. 2012 Dec;259(12):2621-31. doi: 10.1007/s00415-012-6557-8. Epub 2012 Jun 19.

PMID:
22711157
25.

Sad and happy facial emotion recognition impairment in progressive supranuclear palsy in comparison with Parkinson's disease.

Pontieri FE, Assogna F, Stefani A, Pierantozzi M, Meco G, Benincasa D, Colosimo C, Caltagirone C, Spalletta G.

Parkinsonism Relat Disord. 2012 Aug;18(7):871-5. doi: 10.1016/j.parkreldis.2012.04.023. Epub 2012 May 15.

PMID:
22595619
26.

The validity and reliability of the Italian Olfactory Identification Test (IOIT) in healthy subjects and in Parkinson's disease patients.

Maremmani C, Rossi G, Tambasco N, Fattori B, Pieroni A, Ramat S, Napolitano A, Vanni P, Serra P, Piersanti P, Zanetti M, Coltelli M, Orsini M, Marconi R, Purcaro C, Rossi A, Calabresi P, Meco G.

Parkinsonism Relat Disord. 2012 Jul;18(6):788-93. doi: 10.1016/j.parkreldis.2012.03.021. Epub 2012 Apr 15.

PMID:
22510205
27.

Frontal assessment battery scores and non-motor symptoms in parkinsonian disorders.

Marconi R, Antonini A, Barone P, Colosimo C, Avarello TP, Bottacchi E, Cannas A, Ceravolo MG, Ceravolo R, Cicarelli G, Gaglio RM, Giglia L, Iemolo F, Manfredi M, Meco G, Nicoletti A, Pederzoli M, Petrone A, Pisani A, Pontieri FE, Quatrale R, Ramat S, Scala R, Volpe G, Zappulla S, Bentivoglio AR, Stocchi F, Trianni G, Del Dotto P, De Gaspari D, Grasso L, Morgante F, Santangelo G, Fabbrini G, Morgante L; PRIAMO study group.

Neurol Sci. 2012 Jun;33(3):585-93. doi: 10.1007/s10072-011-0807-x. Epub 2011 Nov 3.

PMID:
22048791
28.

Psychosis associated to Parkinson's disease in the early stages: relevance of cognitive decline and depression.

Morgante L, Colosimo C, Antonini A, Marconi R, Meco G, Pederzoli M, Pontieri FE, Cicarelli G, Abbruzzese G, Zappulla S, Ramat S, Manfredi M, Bottacchi E, Abrignani M, Berardelli A, Cozzolino A, Paradiso C, De Gaspari D, Morgante F, Barone P; PRIAMO Study Group.

J Neurol Neurosurg Psychiatry. 2012 Jan;83(1):76-82. doi: 10.1136/jnnp-2011-300043. Epub 2011 Aug 11.

PMID:
21836035
29.

A simplified algorithm may lead to overestimate dementia in PD. A clinical and epidemiological study using criteria for PD-D proposed by the Movement Disorders Task Force.

Di Battista ME, Giustini P, Bernardi S, Stirpe P, Vanacore N, Meco G.

J Neural Transm (Vienna). 2011 Nov;118(11):1609-12. doi: 10.1007/s00702-011-0638-1. Epub 2011 Apr 10.

PMID:
21479865
30.

Excessive daytime sleepiness in multiple system atrophy (SLEEMSA study).

Moreno-López C, Santamaría J, Salamero M, Del Sorbo F, Albanese A, Pellecchia MT, Barone P, Overeem S, Bloem B, Aarden W, Canesi M, Antonini A, Duerr S, Wenning GK, Poewe W, Rubino A, Meco G, Schneider SA, Bhatia KP, Djaldetti R, Coelho M, Sampaio C, Cochen V, Hellriegel H, Deuschl G, Colosimo C, Marsili L, Gasser T, Tolosa E.

Arch Neurol. 2011 Feb;68(2):223-30. doi: 10.1001/archneurol.2010.359.

PMID:
21320989
31.

Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry.

Köllensperger M, Geser F, Ndayisaba JP, Boesch S, Seppi K, Ostergaard K, Dupont E, Cardozo A, Tolosa E, Abele M, Klockgether T, Yekhlef F, Tison F, Daniels C, Deuschl G, Coelho M, Sampaio C, Bozi M, Quinn N, Schrag A, Mathias CJ, Fowler C, Nilsson CF, Widner H, Schimke N, Oertel W, Del Sorbo F, Albanese A, Pellecchia MT, Barone P, Djaldetti R, Colosimo C, Meco G, Gonzalez-Mandly A, Berciano J, Gurevich T, Giladi N, Galitzky M, Rascol O, Kamm C, Gasser T, Siebert U, Poewe W, Wenning GK; EMSA-SG.

Mov Disord. 2010 Nov 15;25(15):2604-12. doi: 10.1002/mds.23192.

PMID:
20922810
32.

Lack of association between IL-1β, TNF-α, and IL-10 gene polymorphisms and sporadic Parkinson's disease in an Italian cohort.

Pascale E, Passarelli E, Purcaro C, Vestri AR, Fakeri A, Guglielmi R, Passarelli F, Meco G.

Acta Neurol Scand. 2011 Sep;124(3):176-81. doi: 10.1111/j.1600-0404.2010.01441.x. Epub 2010 Sep 29.

PMID:
20880267
33.

Transcranial sonographic findings in Wilson disease.

Ricciardi MC, Sirimarco G, Vicenzini E, Zuco C, Meco G, Di Piero V, Lenzi GL.

J Ultrasound Med. 2010 Jul;29(7):1143-5. No abstract available.

PMID:
20587439
34.

Bladder symptoms assessed with overactive bladder questionnaire in Parkinson's disease.

Iacovelli E, Gilio F, Meco G, Fattapposta F, Vanacore N, Brusa L, Giacomelli E, Gabriele M, Rubino A, Locuratolo N, Iani C, Pichiorri F, Colosimo C, Carbone A, Palleschi G, Inghilleri M.

Mov Disord. 2010 Jul 15;25(9):1203-9. doi: 10.1002/mds.23093.

PMID:
20310046
35.

Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study.

Colosimo C, Morgante L, Antonini A, Barone P, Avarello TP, Bottacchi E, Cannas A, Ceravolo MG, Ceravolo R, Cicarelli G, Gaglio RM, Giglia L, Iemolo F, Manfredi M, Meco G, Nicoletti A, Pederzoli M, Petrone A, Pisani A, Pontieri FE, Quatrale R, Ramat S, Scala R, Volpe G, Zappulla S, Bentivoglio AR, Stocchi F, Trianni G, Del Dotto P, Simoni L, Marconi R; PRIAMO STUDY GROUP.

J Neurol. 2010 Jan;257(1):5-14. doi: 10.1007/s00415-009-5255-7. Epub 2009 Aug 9.

PMID:
19669613
36.

Aripiprazole in L-dopa-induced dyskinesias: a one-year open-label pilot study.

Meco G, Stirpe P, Edito F, Purcaro C, Valente M, Bernardi S, Vanacore N.

J Neural Transm (Vienna). 2009 Jul;116(7):881-4. doi: 10.1007/s00702-009-0231-z. Epub 2009 May 12.

PMID:
19533295
37.

The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease.

Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello TP, Bottacchi E, Cannas A, Ceravolo G, Ceravolo R, Cicarelli G, Gaglio RM, Giglia RM, Iemolo F, Manfredi M, Meco G, Nicoletti A, Pederzoli M, Petrone A, Pisani A, Pontieri FE, Quatrale R, Ramat S, Scala R, Volpe G, Zappulla S, Bentivoglio AR, Stocchi F, Trianni G, Dotto PD; PRIAMO study group.

Mov Disord. 2009 Aug 15;24(11):1641-9. doi: 10.1002/mds.22643.

PMID:
19514014
38.

GIGYF2 mutations are not a frequent cause of familial Parkinson's disease.

Di Fonzo A, Fabrizio E, Thomas A, Fincati E, Marconi R, Tinazzi M, Breedveld GJ, Simons EJ, Chien HF, Ferreira JJ, Horstink MW, Abbruzzese G, Borroni B, Cossu G, Dalla Libera A, Fabbrini G, Guidi M, De Mari M, Lopiano L, Martignoni E, Marini P, Onofrj M, Padovani A, Stocchi F, Toni V, Sampaio C, Barbosa ER, Meco G; Italian Parkinson Genetics Network, Oostra BA, Bonifati V.

Parkinsonism Relat Disord. 2009 Nov;15(9):703-5. doi: 10.1016/j.parkreldis.2009.05.001. Epub 2009 May 31.

PMID:
19482505
39.

Genetic polymorphism of Angiotensin-Converting Enzyme is not associated with the development of Parkinson's disease and of L-dopa-induced adverse effects.

Pascale E, Purcaro C, Passarelli E, Guglielmi R, Vestri AR, Passarelli F, Meco G.

J Neurol Sci. 2009 Jan 15;276(1-2):18-21. doi: 10.1016/j.jns.2008.08.017. Epub 2008 Sep 20.

PMID:
18805557
40.

Red flags for multiple system atrophy.

Köllensperger M, Geser F, Seppi K, Stampfer-Kountchev M, Sawires M, Scherfler C, Boesch S, Mueller J, Koukouni V, Quinn N, Pellecchia MT, Barone P, Schimke N, Dodel R, Oertel W, Dupont E, Østergaard K, Daniels C, Deuschl G, Gurevich T, Giladi N, Coelho M, Sampaio C, Nilsson C, Widner H, Sorbo FD, Albanese A, Cardozo A, Tolosa E, Abele M, Klockgether T, Kamm C, Gasser T, Djaldetti R, Colosimo C, Meco G, Schrag A, Poewe W, Wenning GK; European MSA Study Group.

Mov Disord. 2008 Jun 15;23(8):1093-9. doi: 10.1002/mds.21992.

PMID:
18442131
41.

Sexual dysfunction in Parkinson's disease.

Meco G, Rubino A, Caravona N, Valente M.

Parkinsonism Relat Disord. 2008 Aug;14(6):451-6. doi: 10.1016/j.parkreldis.2007.10.008. Epub 2008 Mar 3. Review.

PMID:
18316235
42.

High prevalence of extrapyramidal signs and symptoms in a group of Italian dental technicians.

Fabrizio E, Vanacore N, Valente M, Rubino A, Meco G.

BMC Neurol. 2007 Aug 8;7:24.

43.

ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease.

Di Fonzo A, Chien HF, Socal M, Giraudo S, Tassorelli C, Iliceto G, Fabbrini G, Marconi R, Fincati E, Abbruzzese G, Marini P, Squitieri F, Horstink MW, Montagna P, Libera AD, Stocchi F, Goldwurm S, Ferreira JJ, Meco G, Martignoni E, Lopiano L, Jardim LB, Oostra BA, Barbosa ER; Italian Parkinson Genetics Network, Bonifati V.

Neurology. 2007 May 8;68(19):1557-62.

PMID:
17485642
44.

Biological effects of the PINK1 c.1366C>T mutation: implications in Parkinson disease pathogenesis.

Grünewald A, Breedveld GJ, Lohmann-Hedrich K, Rohé CF, König IR, Hagenah J, Vanacore N, Meco G, Antonini A, Goldwurm S, Lesage S, Dürr A, Binkofski F, Siebner H, Münchau A, Brice A, Oostra BA, Klein C, Bonifati V.

Neurogenetics. 2007 Apr;8(2):103-9. Epub 2007 Jan 12.

PMID:
17219214
45.

Levetiracetam in tardive dyskinesia.

Meco G, Fabrizio E, Epifanio A, Morgante F, Valente M, Vanacore N, Di Rosa AE, Morgante L.

Clin Neuropharmacol. 2006 Sep-Oct;29(5):265-8.

PMID:
16960471
46.

Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.

Meco G, Bernardi S.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jan 30;31(1):311-3. Epub 2006 Aug 17.

PMID:
16919377
47.

Health-related quality of life in multiple system atrophy.

Schrag A, Geser F, Stampfer-Kountchev M, Seppi K, Sawires M, Köllensperger M, Scherfler C, Quinn N, Pellecchia MT, Barone P, Del Sorbo F, Albanese A, Ostergaard K, Dupont E, Cardozo A, Tolosa E, Nilsson CF, Widner H, Lindvall O, Giladi N, Gurevich T, Daniels C, Deuschl G, Coelho M, Sampaio C, Abele M, Klockgether T, Schimke N, Eggert KM, Oertel W, Djaldetti R, Colosimo C, Meco G, Poewe W, Wenning GK; European MSA-Study Group.

Mov Disord. 2006 Jun;21(6):809-15.

PMID:
16502399
48.

Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease.

Di Fonzo A, Tassorelli C, De Mari M, Chien HF, Ferreira J, Rohé CF, Riboldazzi G, Antonini A, Albani G, Mauro A, Marconi R, Abbruzzese G, Lopiano L, Fincati E, Guidi M, Marini P, Stocchi F, Onofrj M, Toni V, Tinazzi M, Fabbrini G, Lamberti P, Vanacore N, Meco G, Leitner P, Uitti RJ, Wszolek ZK, Gasser T, Simons EJ, Breedveld GJ, Goldwurm S, Pezzoli G, Sampaio C, Barbosa E, Martignoni E, Oostra BA, Bonifati V; Italian Parkinson's Genetics Network.

Eur J Hum Genet. 2006 Mar;14(3):322-31.

49.

The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor.

Goldwurm S, Di Fonzo A, Simons EJ, Rohé CF, Zini M, Canesi M, Tesei S, Zecchinelli A, Antonini A, Mariani C, Meucci N, Sacilotto G, Sironi F, Salani G, Ferreira J, Chien HF, Fabrizio E, Vanacore N, Dalla Libera A, Stocchi F, Diroma C, Lamberti P, Sampaio C, Meco G, Barbosa E, Bertoli-Avella AM, Breedveld GJ, Oostra BA, Pezzoli G, Bonifati V.

J Med Genet. 2005 Nov;42(11):e65.

50.

Belly dance syndrome due to spinal myoclonus.

Inghilleri M, Conte A, Frasca V, Vaudano AE, Meco G.

Mov Disord. 2006 Mar;21(3):394-6.

PMID:
16211614

Supplemental Content

Support Center